Global Alpha-1 Lung Disease Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Alpha-1 Lung Disease Market Size 2017-2028

2.1.2 Alpha-1 Lung Disease Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Alpha-1 Lung Disease Segment by Type

2.2.1 Augmentation Therapy

2.2.2 Cystic Fibrosis(CF)

2.2.3 Non-CF Bronchiectasis(NCFB)

2.2.4 Other

2.3 Alpha-1 Lung Disease Market Size by Type

2.3.1 Alpha-1 Lung Disease Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Alpha-1 Lung Disease Market Size Market Share by Type (2017-2022)

2.4 Alpha-1 Lung Disease Segment by Application

2.4.1 Hospitals

2.4.2 Specialty Clinics

2.4.3 Pharmacies

2.4.4 Others

2.5 Alpha-1 Lung Disease Market Size by Application

2.5.1 Alpha-1 Lung Disease Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Alpha-1 Lung Disease Market Size Market Share by Application (2017-2022)

3 Alpha-1 Lung Disease Market Size by Player

3.1 Alpha-1 Lung Disease Market Size Market Share by Players

3.1.1 Global Alpha-1 Lung Disease Revenue by Players (2020-2022)

3.1.2 Global Alpha-1 Lung Disease Revenue Market Share by Players (2020-2022)

3.2 Global Alpha-1 Lung Disease Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Alpha-1 Lung Disease by Regions

4.1 Alpha-1 Lung Disease Market Size by Regions (2017-2022)

4.2 Americas Alpha-1 Lung Disease Market Size Growth (2017-2022)

4.3 APAC Alpha-1 Lung Disease Market Size Growth (2017-2022)

4.4 Europe Alpha-1 Lung Disease Market Size Growth (2017-2022)

4.5 Middle East & Africa Alpha-1 Lung Disease Market Size Growth (2017-2022)

5 Americas

5.1 Americas Alpha-1 Lung Disease Market Size by Country (2017-2022)

5.2 Americas Alpha-1 Lung Disease Market Size by Type (2017-2022)

5.3 Americas Alpha-1 Lung Disease Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Alpha-1 Lung Disease Market Size by Region (2017-2022)

6.2 APAC Alpha-1 Lung Disease Market Size by Type (2017-2022)

6.3 APAC Alpha-1 Lung Disease Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Alpha-1 Lung Disease by Country (2017-2022)

7.2 Europe Alpha-1 Lung Disease Market Size by Type (2017-2022)

7.3 Europe Alpha-1 Lung Disease Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Alpha-1 Lung Disease by Region (2017-2022)

8.2 Middle East & Africa Alpha-1 Lung Disease Market Size by Type (2017-2022)

8.3 Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Alpha-1 Lung Disease Market Forecast

10.1 Global Alpha-1 Lung Disease Forecast by Regions (2023-2028)

10.1.1 Global Alpha-1 Lung Disease Forecast by Regions (2023-2028)

10.1.2 Americas Alpha-1 Lung Disease Forecast

10.1.3 APAC Alpha-1 Lung Disease Forecast

10.1.4 Europe Alpha-1 Lung Disease Forecast

10.1.5 Middle East & Africa Alpha-1 Lung Disease Forecast

10.2 Americas Alpha-1 Lung Disease Forecast by Country (2023-2028)

10.2.1 United States Alpha-1 Lung Disease Market Forecast

10.2.2 Canada Alpha-1 Lung Disease Market Forecast

10.2.3 Mexico Alpha-1 Lung Disease Market Forecast

10.2.4 Brazil Alpha-1 Lung Disease Market Forecast

10.3 APAC Alpha-1 Lung Disease Forecast by Region (2023-2028)

10.3.1 China Alpha-1 Lung Disease Market Forecast

10.3.2 Japan Alpha-1 Lung Disease Market Forecast

10.3.3 Korea Alpha-1 Lung Disease Market Forecast

10.3.4 Southeast Asia Alpha-1 Lung Disease Market Forecast

10.3.5 India Alpha-1 Lung Disease Market Forecast

10.3.6 Australia Alpha-1 Lung Disease Market Forecast

10.4 Europe Alpha-1 Lung Disease Forecast by Country (2023-2028)

10.4.1 Germany Alpha-1 Lung Disease Market Forecast

10.4.2 France Alpha-1 Lung Disease Market Forecast

10.4.3 UK Alpha-1 Lung Disease Market Forecast

10.4.4 Italy Alpha-1 Lung Disease Market Forecast

10.4.5 Russia Alpha-1 Lung Disease Market Forecast

10.5 Middle East & Africa Alpha-1 Lung Disease Forecast by Region (2023-2028)

10.5.1 Egypt Alpha-1 Lung Disease Market Forecast

10.5.2 South Africa Alpha-1 Lung Disease Market Forecast

10.5.3 Israel Alpha-1 Lung Disease Market Forecast

10.5.4 Turkey Alpha-1 Lung Disease Market Forecast

10.5.5 GCC Countries Alpha-1 Lung Disease Market Forecast

10.6 Global Alpha-1 Lung Disease Forecast by Type (2023-2028)

10.7 Global Alpha-1 Lung Disease Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Alpha-1 Lung Disease Product Offered

11.1.3 Pfizer Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Pfizer Main Business Overview

11.1.5 Pfizer Latest Developments

11.2 Baxter

11.2.1 Baxter Company Information

11.2.2 Baxter Alpha-1 Lung Disease Product Offered

11.2.3 Baxter Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Baxter Main Business Overview

11.2.5 Baxter Latest Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Information

11.3.2 AstraZeneca Alpha-1 Lung Disease Product Offered

11.3.3 AstraZeneca Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AstraZeneca Main Business Overview

11.3.5 AstraZeneca Latest Developments

11.4 Grifols

11.4.1 Grifols Company Information

11.4.2 Grifols Alpha-1 Lung Disease Product Offered

11.4.3 Grifols Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Grifols Main Business Overview

11.4.5 Grifols Latest Developments

11.5 Teva Pharmaceutical Industries

11.5.1 Teva Pharmaceutical Industries Company Information

11.5.2 Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered

11.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Teva Pharmaceutical Industries Main Business Overview

11.5.5 Teva Pharmaceutical Industries Latest Developments

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Information

11.6.2 Boehringer Ingelheim Alpha-1 Lung Disease Product Offered

11.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Boehringer Ingelheim Main Business Overview

11.6.5 Boehringer Ingelheim Latest Developments

11.7 Kamada Ltd

11.7.1 Kamada Ltd Company Information

11.7.2 Kamada Ltd Alpha-1 Lung Disease Product Offered

11.7.3 Kamada Ltd Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Kamada Ltd Main Business Overview

11.7.5 Kamada Ltd Latest Developments

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Information

11.8.2 GlaxoSmithKline Alpha-1 Lung Disease Product Offered

11.8.3 GlaxoSmithKline Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 GlaxoSmithKline Main Business Overview

11.8.5 GlaxoSmithKline Latest Developments

11.9 CSL Behring

11.9.1 CSL Behring Company Information

11.9.2 CSL Behring Alpha-1 Lung Disease Product Offered

11.9.3 CSL Behring Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 CSL Behring Main Business Overview

11.9.5 CSL Behring Latest Developments

11.10 Takeda

11.10.1 Takeda Company Information

11.10.2 Takeda Alpha-1 Lung Disease Product Offered

11.10.3 Takeda Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Takeda Main Business Overview

11.10.5 Takeda Latest Developments

11.11 LFB Biomedicaments

11.11.1 LFB Biomedicaments Company Information

11.11.2 LFB Biomedicaments Alpha-1 Lung Disease Product Offered

11.11.3 LFB Biomedicaments Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 LFB Biomedicaments Main Business Overview

11.11.5 LFB Biomedicaments Latest Developments

11.12 Abeona Therapeutics

11.12.1 Abeona Therapeutics Company Information

11.12.2 Abeona Therapeutics Alpha-1 Lung Disease Product Offered

11.12.3 Abeona Therapeutics Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Abeona Therapeutics Main Business Overview

11.12.5 Abeona Therapeutics Latest Developments

11.13 Biogen

11.13.1 Biogen Company Information

11.13.2 Biogen Alpha-1 Lung Disease Product Offered

11.13.3 Biogen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Biogen Main Business Overview

11.13.5 Biogen Latest Developments

11.14 Vertex Pharmaceuticals

11.14.1 Vertex Pharmaceuticals Company Information

11.14.2 Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered

11.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Vertex Pharmaceuticals Main Business Overview

11.14.5 Vertex Pharmaceuticals Latest Developments

11.15 Baxalta

11.15.1 Baxalta Company Information

11.15.2 Baxalta Alpha-1 Lung Disease Product Offered

11.15.3 Baxalta Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Baxalta Main Business Overview

11.15.5 Baxalta Latest Developments

11.16 Arrowhead Research Corporation

11.16.1 Arrowhead Research Corporation Company Information

11.16.2 Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered

11.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Arrowhead Research Corporation Main Business Overview

11.16.5 Arrowhead Research Corporation Latest Developments

11.17 ProBioGen

11.17.1 ProBioGen Company Information

11.17.2 ProBioGen Alpha-1 Lung Disease Product Offered

11.17.3 ProBioGen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 ProBioGen Main Business Overview

11.17.5 ProBioGen Latest Developments

11.18 Chiesi Pharmaceuticals

11.18.1 Chiesi Pharmaceuticals Company Information

11.18.2 Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered

11.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Chiesi Pharmaceuticals Main Business Overview

11.18.5 Chiesi Pharmaceuticals Latest Developments

11.19 Kedrion Group

11.19.1 Kedrion Group Company Information

11.19.2 Kedrion Group Alpha-1 Lung Disease Product Offered

11.19.3 Kedrion Group Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Kedrion Group Main Business Overview

11.19.5 Kedrion Group Latest Developments

11.20 ProMetic Life Sciences

11.20.1 ProMetic Life Sciences Company Information

11.20.2 ProMetic Life Sciences Alpha-1 Lung Disease Product Offered

11.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 ProMetic Life Sciences Main Business Overview

11.20.5 ProMetic Life Sciences Latest Developments

12 Research Findings and Conclusion

Table 1. Alpha-1 Lung Disease Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Augmentation Therapy

Table 3. Major Players of Cystic Fibrosis(CF)

Table 4. Major Players of Non-CF Bronchiectasis(NCFB)

Table 5. Major Players of Other

Table 6. Alpha-1 Lung Disease Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Alpha-1 Lung Disease Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Alpha-1 Lung Disease Market Size Market Share by Type (2017-2022)

Table 9. Alpha-1 Lung Disease Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Alpha-1 Lung Disease Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Alpha-1 Lung Disease Market Size Market Share by Application (2017-2022)

Table 12. Global Alpha-1 Lung Disease Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Alpha-1 Lung Disease Revenue Market Share by Player (2020-2022)

Table 14. Alpha-1 Lung Disease Key Players Head office and Products Offered

Table 15. Alpha-1 Lung Disease Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Alpha-1 Lung Disease Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Alpha-1 Lung Disease Market Size Market Share by Regions (2017-2022)

Table 20. Americas Alpha-1 Lung Disease Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Alpha-1 Lung Disease Market Size Market Share by Country (2017-2022)

Table 22. Americas Alpha-1 Lung Disease Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Alpha-1 Lung Disease Market Size Market Share by Type (2017-2022)

Table 24. Americas Alpha-1 Lung Disease Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Alpha-1 Lung Disease Market Size Market Share by Application (2017-2022)

Table 26. APAC Alpha-1 Lung Disease Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Alpha-1 Lung Disease Market Size Market Share by Region (2017-2022)

Table 28. APAC Alpha-1 Lung Disease Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Alpha-1 Lung Disease Market Size Market Share by Type (2017-2022)

Table 30. APAC Alpha-1 Lung Disease Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Alpha-1 Lung Disease Market Size Market Share by Application (2017-2022)

Table 32. Europe Alpha-1 Lung Disease Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Alpha-1 Lung Disease Market Size Market Share by Country (2017-2022)

Table 34. Europe Alpha-1 Lung Disease Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Alpha-1 Lung Disease Market Size Market Share by Type (2017-2022)

Table 36. Europe Alpha-1 Lung Disease Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Alpha-1 Lung Disease Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Alpha-1 Lung Disease Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Alpha-1 Lung Disease Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Alpha-1 Lung Disease

Table 45. Key Market Challenges & Risks of Alpha-1 Lung Disease

Table 46. Key Industry Trends of Alpha-1 Lung Disease

Table 47. Global Alpha-1 Lung Disease Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Alpha-1 Lung Disease Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Alpha-1 Lung Disease Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Application (2023-2028)

Table 53. Pfizer Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 54. Pfizer Alpha-1 Lung Disease Product Offered

Table 55. Pfizer Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Pfizer Main Business

Table 57. Pfizer Latest Developments

Table 58. Baxter Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 59. Baxter Alpha-1 Lung Disease Product Offered

Table 60. Baxter Main Business

Table 61. Baxter Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Baxter Latest Developments

Table 63. AstraZeneca Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 64. AstraZeneca Alpha-1 Lung Disease Product Offered

Table 65. AstraZeneca Main Business

Table 66. AstraZeneca Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. AstraZeneca Latest Developments

Table 68. Grifols Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 69. Grifols Alpha-1 Lung Disease Product Offered

Table 70. Grifols Main Business

Table 71. Grifols Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Grifols Latest Developments

Table 73. Teva Pharmaceutical Industries Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 74. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered

Table 75. Teva Pharmaceutical Industries Main Business

Table 76. Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Teva Pharmaceutical Industries Latest Developments

Table 78. Boehringer Ingelheim Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 79. Boehringer Ingelheim Alpha-1 Lung Disease Product Offered

Table 80. Boehringer Ingelheim Main Business

Table 81. Boehringer Ingelheim Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Boehringer Ingelheim Latest Developments

Table 83. Kamada Ltd Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 84. Kamada Ltd Alpha-1 Lung Disease Product Offered

Table 85. Kamada Ltd Main Business

Table 86. Kamada Ltd Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Kamada Ltd Latest Developments

Table 88. GlaxoSmithKline Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 89. GlaxoSmithKline Alpha-1 Lung Disease Product Offered

Table 90. GlaxoSmithKline Main Business

Table 91. GlaxoSmithKline Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. GlaxoSmithKline Latest Developments

Table 93. CSL Behring Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 94. CSL Behring Alpha-1 Lung Disease Product Offered

Table 95. CSL Behring Main Business

Table 96. CSL Behring Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. CSL Behring Latest Developments

Table 98. Takeda Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 99. Takeda Alpha-1 Lung Disease Product Offered

Table 100. Takeda Main Business

Table 101. Takeda Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Takeda Latest Developments

Table 103. LFB Biomedicaments Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 104. LFB Biomedicaments Alpha-1 Lung Disease Product Offered

Table 105. LFB Biomedicaments Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. LFB Biomedicaments Main Business

Table 107. LFB Biomedicaments Latest Developments

Table 108. Abeona Therapeutics Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 109. Abeona Therapeutics Alpha-1 Lung Disease Product Offered

Table 110. Abeona Therapeutics Main Business

Table 111. Abeona Therapeutics Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Abeona Therapeutics Latest Developments

Table 113. Biogen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 114. Biogen Alpha-1 Lung Disease Product Offered

Table 115. Biogen Main Business

Table 116. Biogen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Biogen Latest Developments

Table 118. Vertex Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 119. Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered

Table 120. Vertex Pharmaceuticals Main Business

Table 121. Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Vertex Pharmaceuticals Latest Developments

Table 123. Baxalta Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 124. Baxalta Alpha-1 Lung Disease Product Offered

Table 125. Baxalta Main Business

Table 126. Baxalta Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Baxalta Latest Developments

Table 128. Arrowhead Research Corporation Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 129. Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered

Table 130. Arrowhead Research Corporation Main Business

Table 131. Arrowhead Research Corporation Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. Arrowhead Research Corporation Latest Developments

Table 133. ProBioGen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 134. ProBioGen Alpha-1 Lung Disease Product Offered

Table 135. ProBioGen Main Business

Table 136. ProBioGen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. ProBioGen Latest Developments

Table 138. Chiesi Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 139. Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered

Table 140. Chiesi Pharmaceuticals Main Business

Table 141. Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 142. Chiesi Pharmaceuticals Latest Developments

Table 143. Kedrion Group Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 144. Kedrion Group Alpha-1 Lung Disease Product Offered

Table 145. Kedrion Group Main Business

Table 146. Kedrion Group Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 147. Kedrion Group Latest Developments

Table 148. ProMetic Life Sciences Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors

Table 149. ProMetic Life Sciences Alpha-1 Lung Disease Product Offered

Table 150. ProMetic Life Sciences Main Business

Table 151. ProMetic Life Sciences Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 152. ProMetic Life Sciences Latest Developments

List of Figures

Figure 1. Alpha-1 Lung Disease Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Alpha-1 Lung Disease Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Alpha-1 Lung Disease Market Size Market Share by Type in 2021

Figure 7. Alpha-1 Lung Disease in Hospitals

Figure 8. Global Alpha-1 Lung Disease Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Alpha-1 Lung Disease in Specialty Clinics

Figure 10. Global Alpha-1 Lung Disease Market: Specialty Clinics (2017-2022) & ($ Millions)

Figure 11. Alpha-1 Lung Disease in Pharmacies

Figure 12. Global Alpha-1 Lung Disease Market: Pharmacies (2017-2022) & ($ Millions)

Figure 13. Alpha-1 Lung Disease in Others

Figure 14. Global Alpha-1 Lung Disease Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Alpha-1 Lung Disease Market Size Market Share by Application in 2021

Figure 16. Global Alpha-1 Lung Disease Revenue Market Share by Player in 2021

Figure 17. Global Alpha-1 Lung Disease Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Alpha-1 Lung Disease Market Size 2017-2022 ($ Millions)

Figure 19. APAC Alpha-1 Lung Disease Market Size 2017-2022 ($ Millions)

Figure 20. Europe Alpha-1 Lung Disease Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Alpha-1 Lung Disease Market Size 2017-2022 ($ Millions)

Figure 22. Americas Alpha-1 Lung Disease Value Market Share by Country in 2021

Figure 23. Americas Alpha-1 Lung Disease Consumption Market Share by Type in 2021

Figure 24. Americas Alpha-1 Lung Disease Market Size Market Share by Application in 2021

Figure 25. United States Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Alpha-1 Lung Disease Market Size Market Share by Region in 2021

Figure 30. APAC Alpha-1 Lung Disease Market Size Market Share by Application in 2021

Figure 31. China Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Alpha-1 Lung Disease Market Size Market Share by Country in 2021

Figure 38. Europe Alpha-1 Lung Disease Market Size Market Share by Type in 2021

Figure 39. Europe Alpha-1 Lung Disease Market Size Market Share by Application in 2021

Figure 40. Germany Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application in 2021

Figure 48. Egypt Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Alpha-1 Lung Disease Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 54. APAC Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 55. Europe Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 57. United States Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 58. Canada Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 61. China Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 62. Japan Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 63. Korea Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 65. India Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 66. Australia Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 67. Germany Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 68. France Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 69. UK Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 70. Italy Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 71. Russia Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 72. Spain Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 75. Israel Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Alpha-1 Lung Disease Market Size 2023-2028 ($ Millions)